Reporter: Why is your company in a good position for novel drug development. CEO: We have always been a consumer company but the goal has always been how are we empowering individuals and how are we changing the trajectory of healthcare, and change it from empowering individuals to get access to their own genetic information as well as changing by helping leverage crowdsourcing data so that we can cure disease